CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (DEFICIENCY) (Unaudited) - USD ($) |
Total |
Series E Preferred Stocks |
Common Stock |
Preferred Stock |
Paid In Capital |
Shares To Be Issued |
Treasury Stock |
Other Comp Income (loss) |
Accumulated Deficit |
|---|---|---|---|---|---|---|---|---|---|
| Balance, shares at Dec. 31, 2024 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, amount at Dec. 31, 2024 | $ 1,018,414 | $ 2,500,000 | $ 293,157 | $ 40,000 | $ 69,131,186 | $ (95,023) | $ (1,788,699) | $ (69,062,207) | |
| Balance, Treasury Shares at Dec. 31, 2024 | 37,180 | ||||||||
| Sales Issued for Services, Value | 240,000 | $ 240,000 | |||||||
| Stock-based compensation - Vesting | 586,664 | 586,664 | |||||||
| Other Comprehensive Income | 967,622 | 967,622 | |||||||
| Net income | 1,105,398 | 1,105,398 | |||||||
| Balance, shares at Jun. 30, 2025 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, Treasury Shares at Jun. 30, 2025 | 37,180 | ||||||||
| Balance, amount at Jun. 30, 2025 | 3,918,098 | $ 2,500,000 | $ 293,157 | $ 40,000 | 69,717,850 | 240,000 | $ (95,023) | (821,077) | (67,956,809) |
| Balance, shares at Mar. 31, 2025 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, amount at Mar. 31, 2025 | 1,833,505 | $ 2,500,000 | $ 293,157 | $ 40,000 | 69,382,893 | $ (95,023) | (1,826,691) | (68,460,831) | |
| Balance, Treasury Shares at Mar. 31, 2025 | 37,180 | ||||||||
| Sales Issued for Services, Value | 240,000 | 240,000 | |||||||
| Stock-based compensation - Vesting | 334,957 | 334,957 | |||||||
| Other Comprehensive Income | 1,005,614 | 1,005,614 | |||||||
| Net income | 504,022 | 504,022 | |||||||
| Balance, shares at Jun. 30, 2025 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, Treasury Shares at Jun. 30, 2025 | 37,180 | ||||||||
| Balance, amount at Jun. 30, 2025 | 3,918,098 | $ 2,500,000 | $ 293,157 | $ 40,000 | 69,717,850 | $ 240,000 | $ (95,023) | (821,077) | (67,956,809) |
| Balance, shares at Dec. 31, 2025 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, amount at Dec. 31, 2025 | $ (1,094,950) | $ 2,500,000 | $ 293,157 | $ 40,000 | 70,168,395 | $ (95,023) | (8,647,513) | (65,353,966) | |
| Balance, Treasury Shares at Dec. 31, 2025 | 37,180 | 37,180 | |||||||
| Issued shares of common stock | 833,333 | ||||||||
| Issuance of Common Stock , Amount | $ 1,000,000 | $ 8,333 | 991,667 | ||||||
| Stock-based compensation - Vesting | 831,834 | 831,834 | |||||||
| Other Comprehensive Income | 337,501 | 337,501 | |||||||
| Net income | $ 3,164,495 | 3,164,495 | |||||||
| Balance, shares at Jun. 30, 2026 | 30,149,059 | 1,552,795 | 30,149,059 | 1 | |||||
| Balance, Treasury Shares at Jun. 30, 2026 | 37,180 | 37,180 | |||||||
| Balance, amount at Jun. 30, 2026 | $ 4,238,880 | $ 2,500,000 | $ 301,490 | $ 40,000 | 71,991,896 | $ (95,023) | (8,310,012) | (62,189,471) | |
| Balance, shares at Mar. 31, 2026 | 1,552,795 | 29,315,726 | 1 | ||||||
| Balance, amount at Mar. 31, 2026 | 2,242,513 | $ 2,500,000 | $ 293,157 | $ 40,000 | 70,351,574 | $ (95,023) | (8,027,374) | (62,819,821) | |
| Balance, Treasury Shares at Mar. 31, 2026 | 37,180 | ||||||||
| Issued shares of common stock | 833,333 | ||||||||
| Issuance of Common Stock , Amount | 1,000,000 | $ 8,333 | 991,667 | ||||||
| Stock-based compensation - Vesting | 648,655 | 648,655 | |||||||
| Other Comprehensive Income | (282,638) | (282,638) | |||||||
| Net income | $ 630,350 | 630,350 | |||||||
| Balance, shares at Jun. 30, 2026 | 30,149,059 | 1,552,795 | 30,149,059 | 1 | |||||
| Balance, Treasury Shares at Jun. 30, 2026 | 37,180 | 37,180 | |||||||
| Balance, amount at Jun. 30, 2026 | $ 4,238,880 | $ 2,500,000 | $ 301,490 | $ 40,000 | $ 71,991,896 | $ (95,023) | $ (8,310,012) | $ (62,189,471) |
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) allocated to other comprehensive income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|